Cardiovascular Surgery

doi: 10.25005/2074-0581-2019-21-3-436-442
FAVORABLE CLINICAL COURSE OF POSTTHROMBOTIC SYNDROME – THE INDICATOR OF THE EFFECTIVENESS OF TREATMENT OF DEEP VEIN THROMBOSIS

D.R. Radzhabov1, D.D. Sultanov1, F.M. Makhmadalizoda2

1Department of Surgical Diseases № 2, Avicenna Tajik State Medical University, Dushanbe, Republic of Tajikistan
2City Medical Center № 2 named after academician K.T. Tadzhiev, Dushanbe, Republic of Tajikistan

Objective: Evaluation of the effectiveness of conservative treatment of patients in the acute period of deep vein thrombosis (DVT) by exploring the course of the postthrombotic syndrome (PTS) in the short and long term observation.

Methods: Analyzed the results of the examination and treatment of 105 patients with DVT of lower limbs between the period of 2015 and 2018. Patients were divided into two groups. The first (main) group included 40 patients who were treated under the new treatment regimen developed by us. In this group, patients were examined and treated inpatient by an angiosurgeon in the conditions of the Vascular Surgery Department. The second (control) group included 65 patients who received treatment in outpatient settings or other prevention facilities without the involvement of a specialist.

Results: In the main group, there was persistent hypocoagulation within the acceptable level, there was a decrease in swelling and tension of the limb, decreased pain syndrome, eliminated secondary spasm of peripheral arteries. In addition, earlier (up to 3 months) signs of rechanneling of the bloodplated segments of the deep veins of the lower limbs were observed in this group. By the end of the second year, recanalization of varying degrees was in 86.4% (against 61% in the control group), which contributed to the easier flow of PTS. In many ways, it was the degree of recanalization that determined the severity of the PTD. In the control group in the acute period of DVT did not receive treatment at all – 13 patients, outpatient treatment in different specialists were 27, the remaining 25 were treated in the non-specialized hospital of other divisions. The therapy that was given by patients of the control group without proper control of the clotting system of blood and subsequently without rehabilitation measures can be regarded as not optimal management of patients. The examination conducted in the long term with the initial treatment of a vascular surgeon showed worse results compared to the main group. Thus, 39% of patients retained occlusion of the thrombosed venous segment, that was significantly above the average. This fact indicates that this group has seen a slowdown in the rechanneling of the deep veins of the lower limbs, apparently due to the inefficiency of the obtained acute treatment, which contributed to the more severe current of PTS.

Conclusion: The favorable and relatively mild clinical course of PTS was observed in the main group, whereas the control group was dominated by patients with severe currents. At the same time, occlusive forms were observed in 39% of patients in the control and in 13.6% of patients in the main group.

Keywords: Deep vein thrombosis, postthrombotic syndrome, chronic venous insufficiency, pulmonary artery thromboembolism, duplex scan.

Download file:


References
  1. Sultanov DD, Azizov AA, Avgonov UM. Nekotorye voprosy patogeneza khronicheskoy venoznoy nedostatochnosti pri posttromboticheskoy bolezni [Some issues of the pathogenesis of chronic venous insufficiency in post-thrombotic disease]. Vestnik Avitsenny [Avicenna Bulletin]. 2010;1:134-43.
  2. Sultanov DD, Toirov MG, Kurbanova MO. Protsess rekanalizatsii v rannem periode posle perenesyonnogo ostrogo TGV nizhnikh konechnostey [The process of recanalization in the early period after suffering acute DVT of the lower extremities]. Vestnik Avitsenny [Avicenna Bulletin]. 2008;1:18-20.
  3. Usov SA, Rovenskikh DN, Sartakov GG. Struktura faktorov riska ostrogo tromboza glubokikh ven nizhnikh konechnostey [The structure of risk factors for acute deep vein thrombosis of the lower extremities]. Byulleten’ VSTSN SO RAMN. 2012;4:106-7.
  4. Lebedev AK, Kuznetsova OYu. Tromboz glubokikh ven nizhnikh konechnostey [Deep vein thrombosis of the lower extremities]. Rossiyskiy semeynyy vrach. 2015;3:5-16.
  5. Kuznetsov MR, Sapelkin SV. Rekanalizatsiya glubokikh ven nizhnikh konechnostey kak pokazatel’ effektivnosti lecheniya ostrogo venoznogo tromboza [Recanalization of deep veins of the lower extremities as an indicator of the effectiveness of treatment of acute venous thrombosis]. Flebologiya. 2016;3:82-7.
  6. Sultanov DD, Azizov AA, Kamolov AN. Metody operativnikh vmeshatel’stv pri posttromboticheskoy bolezni goleni. Angiologiya i sosudistaya khirurgiya. 2011;17(2):89-94.
  7. Bates SM, Jaeschke R, Stevens SM, Goodacre S, Wells PS, Stevenson MD, et al. Diagnosis of DVT. Antithrombotic therapy and prevention of thrombosis, 9th ed.: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2):351-418. Available from: https://doi. org/10.1378/chest.11-2299.
  8. Carey WD. (ed.) Current clinical medicine. Elsevier; 2008. 1440 p.
  9. Holzhauer S, Goldenberg NA, Junker R, Manner D, Nowak-öttl U, Heller C, et al. Inherited thrombophilia in children with venous thromboembolism and the familial risk of thromboembolism: an observational study. Blood. 2012;120:1510-5.
  10. Gilyarov MYu, Konstantinova YuV. Kakim obrazom novye podkhody k terapii tromboembolii lyogochnoy arterii vliyayut na iskhody zabolevaniya? [How do new approaches to the treatment of pulmonary embolism affect the outcome of the disease?]. Meditsinskiy sovet. 2017;7:48-55.
  11. Bernshteyn LL. Tromboemboliya lyogochnoy arterii: printsipy diagnostiki, antitromboticheskaya terapiya i profilaktika [Pulmonary embolism: principles of diagnosis, antithrombotic therapy and prevention]. Kardiologiya i angiologiya. 2013;43(3):34-44.
  12. Guidelines for the diagnosis, treatment and prevention of pulmonary thromboembolism and deep vein thrombosis (JCS 2009). JCS Joint Working Group. Circ J. 2011;75(5):1258-81.
  13. Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, et al. Investigators oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med. 2013;369:799-808.
  14. Hull RD, Gersh MH. The current landscape of treatment options for venous thromboembolism: a focus on novel oral anticoagulants. Curr Med Res Opin. 2015;31(2):197-210.
  15. Arcelus JI, Domenech P, Fernández-Capitan MDC, Guijarro R, Jiménez D, Jiménez S, et al. Rivaroxaban in the treatment of venous thromboembolism and the prevention of recurrences: a practical approach. Clin Appl Thromb Hemost. 2015;21(4):297-308.
  16. Guyatt GH, Akl EA, Crowther M. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed.: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2):7-47. Available from: https://doi.org/10.1378/chest.1412S3.
  17. Kahn SR, Lim W, Dunn AS, Cushman M, Dentali F, Aki EA, et al. Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of Thrombosis, 9th ed.: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2):195-226. Available from: https://doi.org/10.1378/chest.11-2296.
  18. Rich K. Iliofemoral deep vein thrombosis: Percutaneus endovascular treatment options. J Vasc Nurs Jun. 2015;33(2):47-53.
  19. Schulman S, Kakkar AK, Goldhaber SZ, Schellong S, Ericsson H, Mismetti P, et al. Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis. Circulation. 2014;129(7):764-72. Available from: https://doi.org/10.1161/CIRCULATIONAHA.113.004450.
  20. Sultanov DD, Gaibov AD, Toirov MG Antikoagulyantnaya terapia v kompleksnom lechenii ostrogo tromboza glubokikh ven nizhnikh konechnostey [Anticoaulant therapy in complex treatment DVT]. Angiologiya i sosudistaya khirurgia. 2013;19(2):11-6.
  21. Sobieraj DM, Coleman CI, Pasupuleti V, Deshpande A, Kaw R, Hernandez AV. Comparative efficacy and safety of anticoagulants and aspirin for extended treatment of venous thromboembolism: A network meta-analysis. Thromb Res. 2015;135(5):888-96.
  22. Kalinin RE, Suchkov IA, Pshennikov AS, Agapov AB. Ul’trazvukovaya dinamika lizisa golovki tromba kak ob”ektivnyy kriteriy effektivnosti antikoagulyantnoy terapii pri venoznykh trombozakh [Ultrasonic dynamics of thrombus head lysis as an objective criterion of the effectiveness of anticoagulant therapy in venous thrombosis]. Khirurgiya. 2016;2:61-5.
  23. Zhu T, Martinez I, Emmerich I. Venous thromboembolism: risk factors for recurrence. Arterioscler Thromb Vasc Biol. 2009;29(3):298-310.

Authors' information:


Radzhabov Doriyush Radzhabovich
Postgraduate Student, Department of Surgical Diseases № 2, Avicenna Tajik State Medical University
ORCID ID: 0000-0003-0933-486X
E-mail: doriyush.rachabov.91@gmail.com

Sultanov Dzhavli Davronovich
Doctor of Medical Sciences, Full Professor, Professor of the Department of Surgical Diseases № 2, Avicenna Tajik State Medical University
ORCID ID: 0000-0001-7935-7763
E-mail: sultanov57@maik.ru

Makhmadalizoda Fayziddin Makhmadali
Candidate of Medical Sciences, Deputy Director of Medical Work, City Medical Center № 2 named after academician K.T. Tadzhiev
ORCID ID: 0000-0001-5954-9522
SPIN: 7517-0607
Author ID: 916-624
E-mail: dr.fayzidin@mail.ru

Information about support in the form of grants, equipment, medications

The authors did not receive financial support from manufacturers of medicines and medical equipment.

Conflicts of interest: No conflict

Address for correspondence:


Radzhabov Doriyush Radzhabovich
Postgraduate Student, Department of Surgical Diseases № 2, Avicenna Tajik State Medical University

734003, Republic of Tajikistan, Dushanbe, Rudaki Ave., 139

Tel.: +992 (988) 755888

E-mail: doriyush.rachabov.91@gmail.com

Materials on the topic: